Egetis Therapeutics AB (publ)

SSE:EGTX.ST

6.07 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q1
Revenue 13.912.132.612.25.96.85.65.14.667.1023.2116.2125.0343.7874.892.57221.48811.71217.0536.1714.43754.90211.0986.7159.6680.7313.58500.1440000000000000000000000000000.0030
Cost of Revenue 3.12.562.353.942.850.254.142.624.15121.67821.00315.66647.82612.03267.75319.29248.19449.93226.26633.63326.10126.23924.24817.99130.7310.88736.120.36610.6847.0476.3713.7177.5111.9143.9937.5517.0437.50613.5776.7997.3391.7442.9821.4621.9174.19718.6012.4190000000000
Gross Profit 10.89.6-29.7-41.7-36.9-43.4-48.5-37.5-19.491-14.576-17.792-9.456-22.792-8.245-62.863-16.72-26.706-38.22-9.213-27.462-21.66428.663-13.15-11.276-21.062-10.157-22.515-20.366-10.54-7.047-6.371-3.717-7.511-1.914-3.993-7.551-7.043-7.506-13.577-6.799-7.339-1.744-2.982-1.462-1.917-4.197-18.601-2.419000000000.0030
Gross Profit Ratio 0.7770.793-0.911-3.418-6.254-6.382-8.661-7.353-4.183-2.052-5.541-1.523-0.91-2.177-12.855-6.501-1.243-3.263-0.54-4.45-4.8830.522-1.185-1.679-2.179-13.914-1.6570-73.19400000000000000000000000000010
Reseach & Development Expenses 40.132.852.951.241.547.952.841.122.64419.68918.50513.74545.910.52100000000000000000000000000000000000000000000
General & Administrative Expenses 21.721.50022.716.9004.9635.3753.7852.3163.9224.494.5072.8841.6072.0993.1593.2184.2332.7242.5912.463.4953.0174.9063.8133.4663.4413.3692.8093.573.413000000000000000000000000
Selling & Marketing Expenses 24.322.60018.317.500000000000000000000000000000000000000000002.742.3731.6331.8192.2491.0150.7490.6940.499
SG&A 4644.156.841.441.330.32817.34.9635.3753.7852.3163.9224.494.5072.8841.6072.0993.1593.2184.2332.7242.5912.463.4953.0174.9063.8133.4663.4413.3692.8093.573.4134.8593.9384.654.73614.9841.6721.4555.2151.4871.3871.61.55111.4961.68602.742.3731.6331.8192.2491.0150.7490.6940.499
Other Expenses -0.1-3.400031.222.312.410.5279.1810-0.353-0.016-0.0565.781-0.0565.489-0.7954.8784.612-2.172-0.5831.784-2.51-1.324-0.573.9213.1761.9991.7991.8721.4030.71.5428.454-2.763-3.468-2.078-1.867-2.954-3.945-3.969-2.593-1.956-2.549-2.512-9.8436.31910.9126.69523.7171.1530.6890.5920.5940.1610.0640.027
Operating Expenses 86.176.952.944.943.331.222.312.415.4914.55614.6559.78311.04911.30810.9317.5457.0967.86110.7927.839.9988.3118.7796.8158.0357.7278.8276.9895.4655.245.2414.2124.274.95513.4131.1520.9822.6372.0751.6311.4121.1571.6151.3791.5711.463-19.0576.31910.9129.43526.092.7862.5082.8411.6090.910.7580.526
Operating Income -75.3-67.3-82.6-86.5-80.3-74.9-78.3-55.4-34.981-29.425-32.62-19.591-33.857-19.613-73.396-24.322-33.802-46.876-17.324-35.292-33.83419.769-23.037-20.601-30.421-18.455-32.168-27.379-16.225-12.325-11.495-7.964-12.021-6.883-8.849-11.465-11.493-12.221-17.641-11.383-12.696-6.87-7.087-4.796-6.037-8.171-8.643-6.319-10.913-9.435-26.09-2.786-2.508-2.841-1.609-0.91-0.755-0.526
Operating Income Ratio -5.417-5.562-2.534-7.09-13.61-11.015-13.982-10.863-7.507-4.143-10.159-3.155-1.352-5.179-15.009-9.456-1.573-4.002-1.016-5.719-7.6250.36-2.076-3.068-3.147-25.281-2.3680-112.674000000000000000000000000000-283.2470
Total Other Income Expenses Net 3.4-7.7-3.50.20.8-0.30.41.51.7370.6084.249-2.938-0.4690.294-2.257-0.404-2.3634.058-5.7563.3994.4223.121-4.6121.7572.212.643-0.7860.017-0.040.0060.15-0.003-0.2030.0230.2860.0350.060.070.0220.1190.0220.0950.3860.288-0.0110.140.3680.6770.3640.1580.6640.3010.02-0.006-0000
Income Before Tax -71.9-75-86.1-86.3-79.5-74.9-77.9-53.9-33.244-28.817-28.371-22.53-34.326-19.315-75.408-24.725-36.165-42.818-23.006-31.893-29.41222.89-22.137-18.844-28.211-15.811-32.128-27.338-16.189-12.281-11.462-7.932-11.984-6.846-8.811-11.431-11.433-12.151-17.706-11.265-12.674-6.775-6.961-4.509-6.048-8.032-8.39-5.642-10.548-9.277-25.426-2.485-2.488-2.847-1.609-0.91-0.755-0.526
Income Before Tax Ratio -5.173-6.198-2.641-7.074-13.475-11.015-13.911-10.569-7.134-4.058-8.836-3.628-1.371-5.1-15.421-9.613-1.683-3.656-1.349-5.168-6.6290.417-1.995-2.806-2.918-21.659-2.3650-112.424000000000000000000000000000-283.2470
Income Tax Expense 0-3.7-0.10.30.8-0.3-0.4-1.5-1.737-0.6080.750.74900.317-2.2630.0450.0424.059-5.7553.3994.4253.122-5.51200-0.001-0.826-0.024-0.076-0.0380.117-0.035-0.24-0.0140.2480.0350.060.070.0870.1310.0850.0950.260.28900.140.3690.677-0.0010.1580.6650.3310.020.0020000
Net Income -71.9-75-86.3-86.2-79.5-74.6-77.5-52.4-31.507-28.209-28.371-22.53-34.326-19.315-75.41-24.726-36.164-42.818-23.006-31.893-29.41222.89-22.137-18.844-28.211-15.811-32.128-27.338-16.189-12.281-11.462-7.932-11.984-6.846-8.811-11.431-11.433-12.151-17.706-11.265-12.674-6.775-6.961-4.509-6.048-8.032-8.39-5.642-10.548-9.277-25.426-2.485-2.488-2.847-1.609-0.91-0.755-0.526
Net Income Ratio -5.173-6.198-2.647-7.066-13.475-10.971-13.839-10.275-6.761-3.972-8.836-3.628-1.371-5.1-15.421-9.614-1.683-3.656-1.349-5.168-6.6290.417-1.995-2.806-2.918-21.659-2.3650-112.424000000000000000000000000000-283.2470
EPS -0.25-0.26-0.3-0.35-0.32-0.31-0.36-0.24-0.16-0.16-0.16-0.13-0.19-0.11-1.39-0.42-0.62-0.73-0.43-0.54-0.520.43-0.45-0.35-0.52-0.29-0.65-0.51-0.3-0.23-0.4-0.25-0.38-0.22-0.31-0.36-0.36-0.39-0.65-0.37-0.43-0.23-0.28-0.17-0.22-0.3-0.33-0.21-0.39-0.34-0.83-0.093-0.14-0.14-4.19-2.17-2.32-1.67
EPS Diluted -0.25-0.26-0.3-0.35-0.32-0.31-0.36-0.24-0.16-0.16-0.17-0.13-0.19-0.11-1.39-0.42-0.62-0.73-0.42-0.54-0.520.43-0.45-0.35-0.52-0.29-0.65-0.51-0.3-0.23-0.4-0.25-0.38-0.22-0.31-0.36-0.36-0.38-0.65-0.37-0.42-0.23-0.28-0.16-0.22-0.29-0.33-0.21-0.39-0.34-0.83-0.093-0.14-0.14-4.19-2.17-2.32-1.67
EBITDA -74.9-70.1-81.7-85.2-78.6-73.7-77.2-53.2-32.534-28.104-31.198-18.174-33.179-18.86-75.18-24.224-33.707-42.763-22.951-31.839-29.35522.939-22.136-18.844-28.211-15.811-32.128-27.338-16.189-12.281-11.462-7.932-11.984-6.846-8.811-11.43-11.432-12.15-17.656-11.252-12.61-6.774-6.977-4.507-6.036-8.031-8.388-5.641-10.547-9.276-8.332-2.454-2.487-2.839-1.609-0.909-0.755-0.526
EBITDA Ratio -5.388-5.793-2.506-6.984-13.322-10.838-13.786-10.431-6.982-3.957-9.716-2.927-1.325-4.98-15.374-9.418-1.569-3.651-1.346-5.159-6.6160.418-1.995-2.806-2.918-21.659-2.3650-112.424000000000000000000000000000-283.050